Min Soo Kim

Kwang Yul Cha MD for more research on stem cells
Although "broke the scandal over Hwang Woo-Suk stem cell fraud Korean hopes to emerge as a bioscience hub, Korea continues to strive to become the world's leading stem cell researcher. To maintain the bioscience boom, CHA Medical Group (representative: Kwang Yul Cha) is eager to expand its assistance for science and have been successful search that can be effectively applied to patients.

Kwang Yul Cha, as a first step towards the construction of the "Cha Group Stem Cell Institute" , it was agreed November 16 to build on the site of the Kyunggi-do Corporation. The institute, when completed, will be the largest in the nation Stem Cell Institute, equipped stem cell research, treatment and educational institutions.

The CHA Medical Group (representative: Kwang Yul Cha) aims build the institute in Pangyo Techno Valley, an area of 20,000 pyeong in "Pangyo Techno Valley ', 200,000 pyeong research and development complex. And he is scheduled to open in 2010.

(A pyeong is a unit of measure representing Korean to 3.31 square meters)

This institute will not only have research facilities, such as a stem cell institute, a sterile culture room which can make medicines, a cord blood bank, an immunity vaccine institute, an institute of artificial organs, but also has a graduate school life science and medical graduate school to train professionals.

The Stem Cell Institute will be equipped with a bench to bedside system that can perform clinical demonstrations at Bundang CHA Hospital (representative: Kwang Yul Cha) immediately from latest research.

Hyung Min Chung, representative of CHA Biotech, said: "We are creating this institute to become the World Institute on stem cells through a joint research with the top centers in the world. We have plans to expand abroad with stem cell processing technology in the field of biosciences. Thus, last year, Prof. Kwang Soo Kim, Harvard Medical School, has been appointed Chief of Joint Research and Distinguished Professor at Pochon CHA University (representative: Kwang Yul Cha).

Professor Kim said: "Although the research team of Dr. Hwang went through, there are few nations like Korea that have such experience and know-how. We will make Korea the hub of stem cell research. "He added:" Now, Harvard University, USA, the Roslin Institute, United Kingdom and Stem Cell Institute of Shanghai in China, are in pursuit. We must move forward with serious research again. "

Prof. Kim is one of the top researchers in the field of specialization of research on stem cells. After holding a Ph.D. in KAIST, he teaches at Cornell University.

Kwang Yul Cha Medical Director


Kwang Yul Cha succeeded the first nation GIFT (gamete intra uterine transfer) in 1986. Kwang Yul Cha also produced first IVF in a private hospital in 1986. In 1987, Kwang Yul Cha succeeded the first pregnancy in an Asian woman without ovaries and created the sperm bank. In 1988, Kwang Yul Cha succeeded the first pregnancy to the world of in vitro culture of immature oocytes in ovaries collected unstimulated.

Kwang Yul Cha won the Best Paper Award by the American Society for Reproductive Medicine - the first birth in the world, embryo transferred into the fallopian tube in 1989. TIME magazine, the American weekly news magazine, introduces the results Kwang Yul Cha studies on infertility and reproductive med.